You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study
|
|---|---|
| Published in |
JAMA Neurology, April 2014
|
| DOI | 10.1001/jamaneurol.2013.6240 |
| Pubmed ID | |
| Authors |
Mikael Cohen, Elisabeth Maillart, Ayman Tourbah, Jérôme De Sèze, Sandra Vukusic, David Brassat, Olivier Anne, Sandrine Wiertlewski, William Camu, Sylvie Courtois, Aurélie Ruet, Marc Debouverie, Emmanuelle Le Page, Olivier Casez, Olivier Heinzlef, Bruno Stankoff, Bertrand Bourre, Giovanni Castelnovo, Audrey Rico, Eric Berger, Jean-Philippe Camdessanche, Gilles Defer, Pierre Clavelou, Abdullatif Al Khedr, Hélène Zephir, Agnès Fromont, Caroline Papeix, Bruno Brochet, Jean Pelletier, Christine Lebrun |
| Abstract |
The safety and efficacy of switching from natalizumab to fingolimod have not yet been evaluated in a large cohort of patients with multiple sclerosis (MS) to our knowledge. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 27% |
| United States | 2 | 13% |
| United Kingdom | 2 | 13% |
| Unknown | 7 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 67% |
| Practitioners (doctors, other healthcare professionals) | 3 | 20% |
| Science communicators (journalists, bloggers, editors) | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| Germany | 1 | <1% |
| Portugal | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 119 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 18% |
| Student > Ph. D. Student | 16 | 13% |
| Other | 15 | 12% |
| Student > Master | 10 | 8% |
| Student > Bachelor | 9 | 7% |
| Other | 23 | 18% |
| Unknown | 30 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 45% |
| Neuroscience | 14 | 11% |
| Agricultural and Biological Sciences | 7 | 6% |
| Nursing and Health Professions | 5 | 4% |
| Economics, Econometrics and Finance | 3 | 2% |
| Other | 10 | 8% |
| Unknown | 30 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2014.
All research outputs
#1,629,453
of 25,373,627 outputs
Outputs from JAMA Neurology
#1,705
of 5,841 outputs
Outputs of similar age
#16,055
of 239,202 outputs
Outputs of similar age from JAMA Neurology
#11
of 84 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.3. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.